智飛生物(300122.SZ):擬推2022年員工持股計劃 籌資上限16億元
格隆匯1月28日丨智飛生物(300122.SZ)公佈公司共同富裕之員工持股計劃草案(2022年),員工持股計劃籌集資金總額不超過16億元,計劃份額合計不超過16億份,每份額金額為人民幣1元。
該員工持股計劃設立後將委託信託計劃、資產管理計劃、私募基金等具備管理資質的專業機構進行管理,並擬通過法律法規允許的方式實現融資金額與自籌金額的比例不超過1:1,管理機構產品的規模上限為32億元。
以管理機構產品的規模上限32億元及2022年1月28日公司收盤價105.62元/股測算,管理機構產品所能購買和持有的標的股票約為3029.73萬股,佔公司股本總額比例約為1.89%,最終持有標的股票的數量以實際執行為準。
員工持股計劃的參加對象均需符合公司制定的標準,參加對象總人數不超過2000人,其中參加員工持股計劃的董事、監事和高級管理人員共計14人。
員工持股計劃的存續期為 48個月,自股東大會審議通過員工持股計劃並且員工持股計劃認購之日起計算,存續期滿可展期;員工持股計劃所涉及的標的股票鎖定期屆滿,且員工持股計劃資產均為貨幣資金時,經管理委員會同意,員工持股計劃可提前終止。員工持股計劃的鎖定期為12個月,自公司公吿最後一筆標的股票過户時起算。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.